Recent Updates
Recently added Catalysts
VNRX Positive Sentiment

Physiologically Relevant NETosis Induction Reveals Distinct Triggers and Chromatin Changes

Monday, June 24, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: The poster titled 'Physiologically Relevant NETosis Induction Reveals Distinct Triggers and Chromatin Changes' was presented at ISTH 2024 by Atteberry et al. It discusses new findings related to NETosis and chromatin accessibility in neutrophils, which may have implications for sepsis research.
Price reaction · baseline $13 (2024-06-21 close) · hit pre-market · 2 other VNRX headline(s) in the window, move may be shared
day 0 close · peak
+4.2%

Market Sentiment Analysis

POSITIVE FACTORS

  • Presentation at a prestigious conference (ISTH 2024)
  • New insights into NETosis induction and chromatin changes
  • Potential implications for understanding sepsis

Full Press Release Details

Poster title: Physiologically Relevant NETosis Induction Reveals Distinct Triggers and Chromatin Changes
Presented at ISTH 2024
Atteberry et al

Related Articles

• Press Releases Data Showing the Prognostic Value of its Nu.Q® Cancer Test
• Poster & Publications Cytokine-induced chromatin accessibility in whole blood neutrophils links to sepsis transcriptional states

Data Showing the Prognostic Value of its Nu.Q® Cancer Test

Cytokine-induced chromatin accessibility in whole blood neutrophils links to sepsis transcriptional states

• Share
• Tweet
• Share on Facebook
• Share

Subscribe for Volition product updates .

Or, click here for Investor Updates and press releases .

" * " indicates required fields

Frequently Asked Questions

What was the focus of the poster presented at ISTH 2024?

The poster focused on NETosis induction and its distinct triggers and chromatin changes.

Who presented the research at ISTH 2024?

The research was presented by Atteberry et al.

What are the implications of the findings on NETosis?

The findings may have implications for understanding sepsis and its transcriptional states.

ShareAdd on Google
Tags: VNRX Viatris Investor Conferences Healthcare NETosis chromatin changes ISTH 2024 sepsis
Last updated: Jun 24, 2024

Biotech snapshot

Cash runway
$3M liquidity · $2M/mo burn
~1 mo
High dilution risk